Latest filing published 02 Jul 2010 for Anthera Pharmaceuticals Inc.
Insider track record
No signal scores available.
Stephen Lau: trading record in brief
Stephen Lau discloses dealings in Anthera Pharmaceuticals Inc to SEC (Form 4). In total, 2 filings cover trades dated 30 June 2010.
Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The newest entry dates from 2 July 2010: a share grant, in Anthera Pharmaceuticals Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Stephen Lau
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,000 sharesCommon StockSEC:0001209191-10-037159:0
- 6,000 sharesCommon StockSEC:0001209191-10-037159:1
2 of 2 declarations